FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathryn Taylor

Research Profile

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Disorders

Breast Neoplasms

Physiology

Anatomy

Living Beings

Cricetinae

Co-author Network

Publications

TOP 3
Kathryn M Taylor; Peter Kille; Christer Hogstrand
Protein kinase CK2 opens the gate for zinc signaling.
Kathryn M Taylor; Robert I Nicholson; Stephen Hiscox; Christer Hogstrand; Peter Kille
Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7.
Nicholas B P Thomas; Iain R Hutcheson; Lee Campbell; Julia Gee; Kathryn M Taylor; Robert I Nicholson; Mark Gumbleton
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathryn Taylor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kathryn M Taylor; Peter Kille; Christer Hogstrand
Protein kinase CK2 opens the gate for zinc signaling.
Cell cycle (Georgetown, Tex.) 2012;11(10):1863-4.
2012: Kathryn M Taylor; Robert I Nicholson; Stephen Hiscox; Christer Hogstrand; Peter Kille
Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7.
Science signaling 2012;5(210):ra11.
2010: Nicholas B P Thomas; Iain R Hutcheson; Lee Campbell; Julia Gee; Kathryn M Taylor; Robert I Nicholson; Mark Gumbleton
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
Breast cancer research and treatment 2010;119(3):575-91.
2008: Kathryn M Taylor
A distinct role in breast cancer for two LIV-1 family zinc transporters.
Biochemical Society transactions 2008;36(Pt 6):1247-51.
2008: Kathryn M Taylor; Petra Vichova; Nicola J Jordan; Stephen Hiscox; Rhiannon Hendley; Robert I Nicholson
ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells.
Endocrinology 2008;149(10):4912-20.
2007: Robert I Nicholson; Iain R Hutcheson; Helen E Jones; Stephen Hiscox; M Giles; Kathryn M Taylor; J M W Gee
Growth factor signalling in endocrine and anti-growth factor resistant breast cancer.
Reviews in endocrine & metabolic disorders 2007;8(3):241-53.
2007: Kathryn M Taylor; Helen E Morgan; Kathryn Smart; Normawati M Zahari; Sara Pumford; Ian O Ellis; John F R Robertson; Robert I Nicholson
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer.
Molecular medicine (Cambridge, Mass.) 2007;13(7-8):396-406.
2005: Kathryn M Taylor; Helen E Morgan; Andrea Johnson; Robert I Nicholson
Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14.
FEBS letters 2005;579(2):427-32.
2004: Kathryn M Taylor; Stephen Hiscox; Robert I Nicholson
Zinc transporter LIV-1: a link between cellular development and cancer progression.
Trends in endocrinology and metabolism: TEM 2004;15(10):461-3.
2004: Kathryn M Taylor; Helen E Morgan; Andrea Johnson; Robert I Nicholson
Structure-function analysis of HKE4, a member of the new LIV-1 subfamily of zinc transporters.
The Biochemical journal 2004;377(Pt 1):131-9.
2003: Kathryn M Taylor; Helen E Morgan; Andrea Johnson; Lisa J Hadley; Robert I Nicholson
Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters.
The Biochemical journal 2003;375(Pt 1):51-9.
2003: Kathryn M Taylor; Robert I Nicholson
The LZT proteins; the LIV-1 subfamily of zinc transporters.
Biochimica et biophysica acta 2003;1611(1-2):16-30.
2001: Eve Glynne-Jones; Maureen E Harper; LT Seery; R James; Ian E Anglin; Helen E Morgan; Kathryn M Taylor; J M W Gee; Robert I Nicholson
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence.
International journal of cancer. Journal international du cancer 2001;94(2):178-84.